Strs Ohio I Teos Therapeutics, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 5,200 shares of ITOS stock, worth $42,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,200

Previous 5,200 -0.0%

Holding current value

$42,796

Previous $77,000 31.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$9.89 - $13.64 $55,384 - $76,384	-5,600 Reduced 51.85%	5,200 $70,000
Q4 2023 Jan 30, 2024	SELL	$8.57 - $11.06 $36,851 - $47,558	-4,300 Reduced 28.48%	10,800 $118,000
Q2 2023 Jul 31, 2023	SELL	$12.93 - $18.05 $253,428 - $353,780	-19,600 Reduced 56.48%	15,100 $199,000
Q1 2023 Aug 02, 2023	BUY	$13.02 - $22.62 $255,192 - $443,352	19,600 Added 129.8%	34,700 $472,000
Q1 2023 Apr 27, 2023	BUY	$13.02 - $22.62 $74,214 - $128,934	5,700 Added 19.66%	34,700 $472,000
Q4 2022 Jan 26, 2023	SELL	$17.77 - $21.6 $56,864 - $69,120	-3,200 Reduced 9.94%	29,000 $566,000
Q3 2022 Oct 27, 2022	BUY	$18.6 - $27.25 $24,180 - $35,425	1,300 Added 4.21%	32,200 $613,000
Q2 2022 Jul 25, 2022	BUY	$16.57 - $35.1 $149,130 - $315,900	9,000 Added 41.1%	30,900 $636,000
Q1 2022 Apr 21, 2022	SELL	$31.92 - $47.45 $25,536 - $37,960	-800 Reduced 3.52%	21,900 $704,000
Q4 2021 Jan 24, 2022	BUY	$26.23 - $47.86 $309,514 - $564,748	11,800 Added 108.26%	22,700 $1.06 Million
Q3 2021 Oct 22, 2021	BUY	$23.91 - $29.58 $260,619 - $322,422	10,900 New	10,900 $294,000
Q2 2021 Jul 26, 2021	SELL	$17.9 - $36.1 $255,969 - $516,230	-14,300 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$30.86 - $44.2 $357,976 - $512,720	11,600 Added 429.63%	14,300 $488,000
Q3 2020 Dec 14, 2020	BUY	$17.57 - $32.92 $47,439 - $88,884	2,700 New	2,700 $66,000

Others Institutions Holding ITOS

# of Institutions

165

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account